Literature DB >> 779997

WHO collaborative evaluation of reference hepatitis B surface antigen and antibody reagents, subtype ad.

P E Taylor.   

Abstract

As a result of a WHO consultation in 1970 a guinea-pig antiserum, V801-501-058, was comprehensively evaluated by 11 collaborating laboratories in order to determine its usefulness as a reference reagent for the detection and assay of hepatitis B surface antigen (HB(s)Ag). The range of titres obtained were 1:64-1:256 by the immunodiffusion technique, 1:64-1:512 by counterimmunoelectrophoresis, 1:256-1:4096 by complement fixation, 1:6400-1:9600 by immune adherence haemagglutination, and <1:32 by platelet aggregation. The sensitivity of the guinea-pig antiserum for the detection of HB(s)Ag in serum and plasma samples was found to be equivalent to that of antisera obtained from other sources (man and baboon) with complement fixation and immune adherence haemagglutination, but it was slightly less sensitive with immunodiffusion and counterimmunoelectrophoresis. HB(s)Ag-positive reagent serum, which was used for the preparation of the immunogen, was found to have titres of 1:16-1:64 by immunodiffusion, 1:32-1:128 by counterimmunoelectrophoresis, 1:512-1:4096 by complement fixation, and 1:256-1:25 600 by immune adherence haemagglutination.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 779997      PMCID: PMC2366366     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  On the rare ayr phenotype of hepatitis B Antigen.

Authors:  G L Le Bouvier; W H Bancroft; P V Holland
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

2.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

3.  Detection of Australia antigen by means of immune adherence haemagglutination test.

Authors:  M Mayumi; K Okochi; K Nishioka
Journal:  Vox Sang       Date:  1971-02       Impact factor: 2.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.